Related Experiment Video For AuNPs
Updated: Aug 28, 2026

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
AuNPs-VS2-Mediated LSPR-SPR-Coupled optical fiber biosensor for sensitive and acid-stable detection of H. pylori
Hongxi Wang1, Jiantao Zhang2, Lingzhu Gou3
1Wuhan Metro Group Co., Ltd., Wuhan, 430000, China.
Abstract:
Early detection of Helicobacter pylori (H. pylori) is critical for preventing gastric diseases and associated carcinogenesis. However, current clinical methods, such as serology and endoscopic biopsy, are often highly invasive or time-consuming, limiting their utility for real-time and in vivo diagnosis. To address this gap, an AuNPs-VS2 composite-sensitized optical fiber surface plasmon resonance (SPR) biosensor was developed for rapid and highly sensitive H. pylori detection. Multilayered 1T-phase VS2 was synthesized to enhance the interfacial electric field and provide abundant sites for antibody immobilization. Positively charged AuNPs were then self-assembled onto carboxylated VS2, enabling synergistic LSPR-SPR coupling and an amplified refractive index response. The optimized probe achieved a refractive index sensitivity of 3718.04 nm/RIU and exhibited a good linear detection range for H. pylori from 101 to 107 CFU/mL, with a sensitivity of 0.88 nm·(lg CFU/mL)-1 and a limit of detection as low as 1.67 CFU/mL. Furthermore, the biosensor demonstrated excellent selectivity, stable signal output, a rapid response time of approximately 34 s, strong acid stability over a pH range of 1-5, and low biotoxicity, underscoring its potential for gastric fluid analysis and future in vivo diagnostic applications.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology

